Breast cancer in HIV-positive women: A report of four cases and review of the literatureVOUTSADAKIS, Ioannis A; SILVERMAN, Lewis R.Cancer investigation. 2002, Vol 20, Num 4, pp 452-457, issn 0735-7907Article

Early epigenetic changes and DNA damage do not predict clinical response in an overlapping schedule of 5-azacytidine and entinostat in patients with myeloid malignanciesFANDY, Tamer E; HERMAN, James G; LICHT, Jonathan et al.Blood. 2009, Vol 114, Num 13, pp 2764-2773, issn 0006-4971, 10 p.Article

Jumping translocations of the long arms of chromosome 1 in myeloid malignancies is associated with a high risk of transformation to acute myeloid leukaemiaNAJFELD, Vesna; TRIPODI, Joseph; SCALISE, Angela et al.British journal of haematology. 2010, Vol 151, Num 3, pp 288-291, issn 0007-1048, 4 p.Article

Effects of azacitidine compared with conventional care regimens in elderly (>75 years) patients with higher-risk myelodysplastic syndromesSEYMOUR, John F; FENAUX, Pierre; BEACH, C. L et al.Critical reviews in oncology/hematology. 2010, Vol 76, Num 3, pp 218-227, issn 1040-8428, 10 p.Article

Postremission therapy with low-dose interleukin 2 with or without intermediate pulse dose interleukin 2 therapy is well tolerated in elderly patients with acute myeloid leukemia: Cancer and Leukemia Group B study 9420FARAG, Sherif S; GEORGE, Stephen L; LARSON, Richard A et al.Clinical cancer research. 2002, Vol 8, Num 9, pp 2812-2819, issn 1078-0432, 8 p.Article

Impact of azacytidine on the quality of life of patients with myelodysplastic syndrome treated in a randomized phase III trial: A Cancer and Leukemia Group B studyKORNBLITH, Alice B; HERNDON, James E; SCHIFFER, Charles A et al.Journal of clinical oncology. 2002, Vol 20, Num 10, pp 2441-2452, issn 0732-183XArticle

Continued Azacitidine Therapy Beyond Time of First Response Improves Quality of Response in Patients With Higher-Risk Myelodysplastic SyndromesSILVERMAN, Lewis R; FENAUX, Pierre; MUFTI, Ghulam J et al.Cancer. 2011, Vol 117, Num 12, pp 2697-2702, issn 0008-543X, 6 p.Article

Randomized controlled trial of azacitidine in Patients with the myelodysplastic syndrome: A study of the cancer and leukemia group BSILVERMAN, Lewis R; DEMAKOS, Erin P; ELLERTON, John et al.Journal of clinical oncology. 2002, Vol 20, Num 10, pp 2429-2440, issn 0732-183XArticle

Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid LeukemiaFENAUX, Pierre; MUFTI, Ghulam J; DOMBRET, Hervé et al.Journal of clinical oncology. 2010, Vol 28, Num 4, pp 562-569, issn 0732-183X, 8 p.Article

Treatment of Myelodysplastic Syndrome With 2 Schedules and Doses of Oral Topotecan : A Randomized Phase 2 Trial by the Cancer and Leukemia Group B (CALGB 19803)GRINBLATT, David L; DAOHAI YU; LARSON, Richard A et al.Cancer. 2009, Vol 115, Num 1, pp 84-93, issn 0008-543X, 10 p.Article

Further analysis of trials with azacitidine in patients with myelodysplastic syndrome : Studies 8421, 8921, and 9221 by the cancer and leukemia group BSILVERMAN, Lewis R; MCKENZIE, David R; PETERSON, Bercedis L et al.Journal of clinical oncology. 2006, Vol 24, Num 24, pp 3895-3903, issn 0732-183X, 9 p.Article